Literature DB >> 11509831

Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum.

M W Jakowec1, D M Donaldson, J Barba, G M Petzinger.   

Abstract

A primary goal of our research is to elucidate the mechanisms involved in neuroplasticity of the basal ganglia in both development and in response to injury. One means to this aim is through the analysis of the ontological profile of proteins in the basal ganglia and to correlate their pattern of expression with morphological development. One protein thought to be important in neuroplasticity is alpha-synuclein. The purpose of this study was to characterize and compare the pattern of expression of alpha-synuclein protein using immunocytochemistry in the substantia nigra and striatum of the rodent in early postnatal and adult life. Our results demonstrate that there is a high level of expression of alpha-synuclein protein within cell bodies of the substantia nigra pars compacta in the 1st week of postnatal life that decreases both in intensity and number of immunoreactive cells between postnatal days 7 and 14. This is in contrast to the substantia nigra pars reticulata where alpha-synuclein protein expression in the neuropil increases after postnatal day 7. In the striatum, expression in early postnatal life is distributed in a mosaic-like fashion and becomes more diffuse after postnatal day 14. Our results support the findings of others that expression of alpha-synuclein is developmentally regulated and suggest that alpha-synuclein may play an important role in establishing the function of the basal ganglia. Understanding the role of alpha-synuclein in the normal basal ganglia may provide insights into the molecular mechanisms involved in neuroplasticity in response to injury. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509831     DOI: 10.1159/000048700

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  8 in total

Review 1.  Alpha-synuclein and dopamine metabolism.

Authors:  Shun Yu; Kenji Uéda; Piu Chan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

2.  Peripheral sensory neurons survive in the absence of alpha- and gamma-synucleins.

Authors:  Katerina Papachroni; Natalia Ninkina; Julia Wanless; Anastasios Th Kalofoutis; Nikolai V Gnuchev; Vladimir L Buchman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

Authors:  Haiyan Lou; Susana E Montoya; Tshianda N M Alerte; Jian Wang; Jianjun Wu; Xiangmin Peng; Chang-Sook Hong; Emily E Friedrich; Samantha A Mader; Courtney J Pedersen; Brian S Marcus; Alison L McCormack; Donato A Di Monte; S Colette Daubner; Ruth G Perez
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

4.  Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Marta G Vucković; Ruth I Wood; Daniel P Holschneider; Avery Abernathy; Daniel M Togasaki; Alexandra Smith; Giselle M Petzinger; Michael W Jakowec
Journal:  Neurobiol Dis       Date:  2008-08-05       Impact factor: 5.996

5.  Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates.

Authors:  Sara Elfarrash; Nanna Møller Jensen; Nelson Ferreira; Cristine Betzer; Jervis Vermal Thevathasan; Robin Diekmann; Mohamed Adel; Nisreen Mansour Omar; Mohamed Z Boraie; Sabry Gad; Jonas Ries; Deniz Kirik; Sadegh Nabavi; Poul Henning Jensen
Journal:  Acta Neuropathol Commun       Date:  2019-12-19       Impact factor: 7.801

6.  Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.

Authors:  Kathryn E Carnazza; Lauren E Komer; Ying Xue Xie; André Pineda; Juan Antonio Briano; Virginia Gao; Yoonmi Na; Trudy Ramlall; Vladimir L Buchman; David Eliezer; Manu Sharma; Jacqueline Burré
Journal:  Cell Rep       Date:  2022-04-12       Impact factor: 9.995

7.  Effect of Parkin on methamphetamine-induced α-synuclein degradation dysfunction in vitro and in vivo.

Authors:  Yunle Meng; Honghua Qiao; Jiuyang Ding; Yitong He; Haoling Fan; Chen Li; Pingming Qiu
Journal:  Brain Behav       Date:  2020-02-21       Impact factor: 2.708

Review 8.  The Role of Alpha-Synuclein and Other Parkinson's Genes in Neurodevelopmental and Neurodegenerative Disorders.

Authors:  C Alejandra Morato Torres; Zinah Wassouf; Faria Zafar; Danuta Sastre; Tiago Fleming Outeiro; Birgitt Schüle
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.